Zobrazeno 1 - 5
of 5
pro vyhledávání: '"C Martín-Blas"'
Autor:
L Rubio-Ruiz, C Martín-Blas, J Sánchez-Rubio, N Ibañez-Heras, T Molina-García, L Martín-Zaragoza, FJ Alonso-Zazo, F Fernández-Fraga
Publikováno v:
Section 4: Clinical pharmacy services.
Autor:
L Morales Martinez, C Saez Bertrand, B Reques, G. Sevilla Santos, M Blasco Guerrero, C Martín Blas
Publikováno v:
Section 4: Clinical Pharmacy Services.
Background Dose adjustment according to estimated glomerular filtration rate (eGFR) in patients with renal failure (RF) is important in avoiding adverse effects, and changes in the intensity and duration of the pharmacological effect. Purpose To asse
Autor:
A Illescas-Bermúdez, P López-Méndez, P Cuder-Martín, E Manjarin-Viñambres, T Molina-García, C Martín-Blas, J Sánchez-Rubio-Ferrández, M Achaques-Rodriguez, M Hijazi Vega, I Patier-Ruiz
Publikováno v:
Eur J Hosp Pharm
BACKGROUND: The proper methods of storage of medicines are of great importance for the maintenance of their stability and therefore their efficacy and safety. Some factors that may affect the drug are: moisture, light, heat, air, time, bacteria and f
Publikováno v:
Clinical pharmacy.
Background Immune thrombocytopenia (ITP) is an autoimmune disease characterised by isolated thrombocytopenia (platelet count 9 /L, without surpassing a maximum dose of 10 µg/kg. There are concerns that starting doses may be too low to obtain normali
Autor:
J Sánchez-Rubio Ferrández, L López Esteban, B Reques Sastre, C Martín Blas, A Onteniente González, T Molina García
Publikováno v:
European Journal of Hospital Pharmacy. 23:A82.3-A83
Background Knowledge of HIV+ patients about their disease and antiretroviral treatment (ART) has been associated with adherence and clinical outcomes. Purpose To determine the degree of knowledge about disease and treatment in HIV+ patients and to an